Bridging the Gap in Lung Cancer: Novel Biomarkers, Metabolic Drivers, and Advanced Therapeutics from Bench to Bedside
Jeongmi Lee, Seung Hyeun Lee · 2026
Read Bridging the Gap in Lung Cancer: Novel Biomarkers, Metabolic Drivers, and Advanced Therapeutics from Bench to Bedside by Jeongmi Lee, Seung Hyeun Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13509177.txt.
Description
Jeongmi Lee and Seung Hyeun Lee introduce a special journal issue on closing the gap between lab discovery and bedside care in lung cancer, in a 2026 editorial. Treatment for both major lung cancer families has entered an era of precision care, the editors argue, powered by translation between bench and clinic. The issue gathers nine papers: eight original studies and one wide review. Topics span protein fingerprints of tumors, metabolic weak points, and radiation planning. Real-world results for immune drugs and messenger RNA vaccines as a fresh immune platform also feature.
These drugs first give striking response rates in patients with the right mutation. Resistance, though, almost always emerges and caps long-term survival, through side mutations or bypass routes. The editors say the collection breaks down walls between molecular biology and practice. Its shared goal is smarter treatment order and longer survivorship for lung cancer patients.
Catalog record
| CREATOR | Jeongmi Lee, Seung Hyeun Lee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |